{"disease":{"id":"healthy-adult-subjects","name":"healthy adult subjects"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05632211","title":"A Study to Investigate the PK, Safety, and Tolerability Between AVT05, US and EU Simponi® in Healthy Adult Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":336,"lead_sponsor_name":"Alvotech Swiss AG","has_results":true},{"nct_id":"NCT05917782","title":"A Study to Evaluate the Pharmacokinetics Similarity of CBP-201 in Healthy Adult Chinese Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":324,"lead_sponsor_name":"Connect Biopharm LLC","has_results":false},{"nct_id":"NCT06701149","title":"A Comparative Study of the Pharmacokinetics of SIM0718 Injection in Healthy Adult Subjects in China","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"Simcere Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT06929052","title":"A Comparative Pharmacokinetic Study of ADL-018 Autoinjector Compared to A Pre-filled Syringe in Healthy Subjects.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Kashiv BioSciences, LLC","has_results":false},{"nct_id":"NCT04586985","title":"Safety, Tolerability and Pharmacokinetics of FTX-6058","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"Fulcrum Therapeutics","has_results":false},{"nct_id":"NCT02691702","title":"Multiple Dose Study Of BIIB118 (PF-05251749) In Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Biogen","has_results":true},{"nct_id":"NCT04481789","title":"Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":true},{"nct_id":"NCT04481750","title":"Study of Oral Edaravone in Healthy Adult Males","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":true},{"nct_id":"NCT04811469","title":"Safety, Tolerability and Pharmacokinetics of CBP-174 in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":74,"lead_sponsor_name":"Connect Biopharma Australia Pty Ltd","has_results":false},{"nct_id":"NCT04370431","title":"A Study of TTYP01 in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Shanghai Auzone Biological Technology Co., Ltd.","has_results":false},{"nct_id":"NCT05061524","title":"A FIH Study of YH35324 in Atopic Healthy Subjects or Subjects with Mild Allergic Diseases","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Yuhan Corporation","has_results":false},{"nct_id":"NCT04433208","title":"Dietary Supplement With and Without a Probiotic","phase":"NA","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Prolacta Bioscience","has_results":true},{"nct_id":"NCT04008186","title":"A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT04596605","title":"Gastrointestinal Tolerance Assessment of T2309","phase":"NA","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Laboratoires Thea","has_results":false},{"nct_id":"NCT05641181","title":"A Trial of CRB4101 in Healthy Subjects","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":48,"lead_sponsor_name":"China Resources Biopharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT05564221","title":"A Multiple Ascending Dose, Phase 1b Study of YH35324 in Atopic Healthy Subjects or Subjects With Allergic Diseases","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Yuhan Corporation","has_results":false},{"nct_id":"NCT04493281","title":"Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":true},{"nct_id":"NCT04979572","title":"A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Taisho Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07515417","title":"Effect of Magnesium Supplementation on Sleep Quality and Cognitive Function in Saudi Adults","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":41,"lead_sponsor_name":"Umm Al-Qura University","has_results":false},{"nct_id":"NCT04203862","title":"A Study of NPC-22 in Healthy Adult Males","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Nobelpharma","has_results":false},{"nct_id":"NCT04521192","title":"Bioequivalence of Fluzoparib(SHR3162) Study on Healthy Chinese Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT06063291","title":"Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"IlDong Pharmaceutical Co Ltd","has_results":false},{"nct_id":"NCT04776135","title":"Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":true},{"nct_id":"NCT06635226","title":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"IlDong Pharmaceutical Co Ltd","has_results":false},{"nct_id":"NCT04629131","title":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Zhuhai Trinomab Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03794180","title":"Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"I-Mab Biopharma US Limited","has_results":false},{"nct_id":"NCT06107205","title":"Bioequivalence of TTYP01 Tablets in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"Shanghai Auzone Biological Technology Co., Ltd.","has_results":false},{"nct_id":"NCT04783766","title":"Safety, Tolerability and Pharmacokinetics Study of CK-3773274","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Corxel Pharmaceuticals","has_results":false},{"nct_id":"NCT04395053","title":"A Bioavailability Study of SHR1459 on Healthy Chinese Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT04291846","title":"A Food Effect Study of SHR1459 on Healthy Chinese Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT06857799","title":"A Study on the Safety, Tolerability and Pharmacokinetics of WS-0101 Tablets in Chinese Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Peking University First Hospital","has_results":false},{"nct_id":"NCT04029090","title":"A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":true},{"nct_id":"NCT05223660","title":"A Phase I Pharmacokinetics Study for KT07 Capsule","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"Yiling Pharmaceutical Inc.","has_results":false},{"nct_id":"NCT04400123","title":"A Bioequivalence Study of Famitinib Malate on Healthy Chinese Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT03960489","title":"A Study to Assess the Relative Bioavailability of Roxadustat Following a Single Dose of Pediatric Azo Dye-free Tablet Formulation and Pediatric Azo Dye-free Mini-tablet Formulation Compared to a Single Dose of Azo Dye-containing Tablet Formulation in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":false},{"nct_id":"NCT03267732","title":"A Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Eli Lilly and Company","has_results":false},{"nct_id":"NCT04494659","title":"A Drug-drug Interaction Trial to Evaluate the Pharmacokinetics Effect of Rifampicin on Famitinib","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT04335266","title":"A Food Effect Study of SHR2554 on Healthy Chinese Male Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT05909644","title":"An Open-label DDI Study of Omaveloxolone in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Biogen","has_results":false},{"nct_id":"NCT04627129","title":"A Itraconazole Effect Study of SHR2554 on Healthy Chinese Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT05002231","title":"Relative Bioavailability and Food Effect Study of Losmapimod 15 mg Tablets","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Fulcrum Therapeutics","has_results":false},{"nct_id":"NCT07084961","title":"A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Taisho Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT05342597","title":"Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Tanabe Pharma Corporation","has_results":true},{"nct_id":"NCT03381547","title":"A 3-Way Crossover Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Eli Lilly and Company","has_results":false},{"nct_id":"NCT04972045","title":"Bioavailability of Curcumin Capsules in Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"The Affiliated Hospital of Qingdao University","has_results":false},{"nct_id":"NCT05334043","title":"Pharmacokinetics and Bioavailability of Curcumin UP 30 Capsules in Healthy Adult Subjects","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":12,"lead_sponsor_name":"The Affiliated Hospital of Qingdao University","has_results":false},{"nct_id":"NCT05040113","title":"A Study On Human Mass Balance And Biotransformation","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Connect Biopharm LLC","has_results":false}],"total":47},"guidelines":[],"source":"Drug Landscape verified database"}